Third Quarter Financial Report

15. Nov 2017 | 2 min read

Moss, 15 November 2017

Gentian Diagnostics AS announces its results for the third quarter. The highlights of the quarter include:

  • 66% growth in sales revenue compared to 3Q16, 16 % y/y
  • New patent protection received after end of period

Please find the report for the third quarter enclosed.

 

For further information, please contact:

Bård Sundrehagen CEO, Gentian Diagnostics
E-mail: Bard.sundrehagen@gentian.no
Cell Phone: +47 924 14 117

 
MeldingsID:  438711
 
 

You may also read


Dec 16, 2019 - Kristin Hart

Financial calendar

Financial calendar for Gentian Diagnostics AS

Dec 05, 2019 - Kristin Hart

Gentian Diagnostics presents at DNB conference in New York

Moss 05.12.19 The CEO of Gentian Diagnostics, Dr. Hilja Ibert, will today give a company presentation at the..

Nov 29, 2019 - Kristin Hart

Share capital increase registered

Reference is made to the stock exchange notice from Gentian Diagnostics AS (the "Company") on 25 November..